A Drug Drug Interaction (DDI) Study of Baricitinib (LY3009104) and Digoxin in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Baricitinib
Related studies linked through entity extraction aliases.
Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study in Moderate to Severe Rheumatoid Arthritis Participants
- Status
- COMPLETED
- Phase
- PHASE3
A Moderate to Severe Rheumatoid Arthritis Study
- Status
- COMPLETED
- Phase
- PHASE3
A Study in Participants With Moderate to Severe Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
A Study in Moderate to Severe Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Oral Baricitinib (LY3009104)Treatment in Japanese Participants With Active Rheumatoid Arthritis on Background Methotrexate Therapy
- Status
- COMPLETED
- Phase
- PHASE2